| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5682920 | La Presse Médicale | 2017 | 15 Pages |
Abstract
Treatment must be adapted to the severity of the disease and goes from conservative observation to systemic chemotherapy. Therapies targeting the RAS-RAF-MEK-ERK pathway are promising treatments for progressive disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Mathilde de Menthon, Véronique Meignin, Alfred Mahr, Abdellatif Tazi,